Patents by Inventor Olga Gherbovet

Olga Gherbovet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUBSTITUTED CYCLIC MODULATORS OF PROTEIN PHOSPHATASE 2A (PP2A) AND METHODS USING SAME
    Publication number: 20240174611
    Abstract: The present disclosure relates in part to chemical modulators of protein phosphatase 2A (PP2A). The compounds of the present disclosure are useful in treating, preventing, and/or ameliorating cancer, diabetes, autoimmune disease, solid organ transplant rejection, graft vs host disease, chronic obstructive pulmonary disease (COPD), non-alcoholic fatty liver disease, abdominal aortic aneurysm, chronic liver disease, heart failure, neurodegenerative disease, and cardiac hypertrophy.
    Type: Application
    Filed: February 7, 2022
    Publication date: May 30, 2024
    Applicant: Rappta Therapeutics Oy
    Inventors: George L. Trainor, Maria Obdulia Rabal Gracia, Laura Fourmois, Olga Gherbovet, Frederic Cachoux
  • MODULATORS OF PROTEIN PHOSPHATASE 2A (PP2A) AND METHODS USING SAME
    Publication number: 20240174603
    Abstract: The present disclosure relates in part to chemical modulators of protein phosphatase 2A (PP2A), comprising formula (I). The compounds of the present disclosure are useful in treating, preventing, and/or ameliorating cancer, diabetes, autoimmune disease, solid organ transplant rejection, graft vs host disease, chronic obstructive pulmonary disease (COPD), non-alcoholic fatty liver disease, abdominal aortic aneurysm, chronic liver disease, heart failure, neurodegenerative disease, and cardiac hypertrophy.
    Type: Application
    Filed: February 7, 2022
    Publication date: May 30, 2024
    Applicant: Rappta Therapeutics Oy
    Inventors: George L. Trainor, Maria Obdulia Rabal Gracia, Laura Fourmois, Olga Gherbovet, Frederic Cachoux